The Ecto-5′-nucleotidase, or CD73, expressed by cancer and stromal cells within CRLM, is a rate-limiting enzyme that enhances the breakdown of ATP-derived extracellular adenosine monophosphate into immunosupressive adenosine [5]. The gene discussed is NT5E; the disease is cancer.